News & Press

PL BioScience Announces Exclusive Distributorship Agreement with SPI

PL BioScience·20 February 2026·1 minute read

PL BioScience GmbH is proud to announce an exclusive distribution agreement for the Japanese market with Summit Pharmaceuticals International Corporation (SPI) to support local availability of …

PL BioScience announces Distributorship Agreement with SPI

PL BioScience announces Exclusive Distributorship Agreement with Summit Pharmaceuticals International (SPI)

PL BioScience GmbH is proud to announce an exclusive distribution agreement for the Japanese market with Summit Pharmaceuticals International Corporation (SPI) to support local availability of Gamma-Irradiated ELAREM™ Ultimate-FD PLUS Human Platelet Lysate and the broader ELAREM™ platform for clinical and research applications.

Read our Press Release here.

Download PDFPDF, opens in a new tab

You might also be interested in.

All News & Media

Graphic welcoming Maik W. Jornitz, Operating Advisor at Avant Bio, to the PL BioScience board

News & Press · 17 Jun 2026New Board Member Maik JornitzPL BioScience has revealed that Maik W. Jornitz has been appointed to its Board of Directors, effective immediately.Read more

Graphic „PMDA Material Qualification Certificate for Regenerative Medical Products“

News & Press · 18 Feb 2026Material Qualification Certificate – PMDAPL BioScience announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has issued a Material Qualification Certificate for ELAREM™ Ultimate-FD PLUS (GMP Grade), the company’s …Read more

Graphic „Welcome to the team, Ole Henrik Bang-Andreasen!“ with his portrait

News & Press · 28 Oct 2025New Board MemberPL BioScience has revealed that Ole Henrik Bang-Andreasen has been appointed to its Board of Directors, following the passing of board member Reinhard Vogt.Read more

Stay informed

Subscribe to receive relevant updates.

News, events and scientific background from PL BioScience — no more than a few times a year.